Lam Research [LRCX] vs Nova [NVMI] Detailed Stock Comparison
Lam Research
NASDAQ
Loading...
Nova
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Lam Research wins in 14 metrics, Nova wins in 5 metrics, with 0 ties. Lam Research appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Lam Research | Nova | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 23.33 | 41.14 | Lam Research |
| Price-to-Book Ratio | 12.45 | 8.13 | Nova |
| Debt-to-Equity Ratio | 45.47 | 24.00 | Nova |
| PEG Ratio | 22.67 | 36.17 | Lam Research |
| EV/EBITDA | 19.56 | 32.97 | Lam Research |
| Profit Margin (TTM) | 29.07% | 28.46% | Lam Research |
| Operating Margin (TTM) | 33.67% | 30.27% | Lam Research |
| EBITDA Margin (TTM) | 33.67% | 30.27% | Lam Research |
| Return on Equity | 58.24% | 23.87% | Lam Research |
| Return on Assets (TTM) | 18.40% | 10.12% | Lam Research |
| Free Cash Flow (TTM) | $4.26B | $218.05M | Lam Research |
| Dividend Yield | 1.00% | N/A | N/A |
| 1-Year Return | 22.73% | 14.31% | Lam Research |
| Price-to-Sales Ratio (TTM) | 6.66 | 10.78 | Lam Research |
| Enterprise Value | $122.95B | $7.68B | Lam Research |
| EV/Revenue Ratio | 6.67 | 10.32 | Lam Research |
| Gross Profit Margin (TTM) | 49.02% | 57.32% | Nova |
| Revenue per Share (TTM) | $14 | $26 | Nova |
| Earnings per Share (Diluted) | $4.15 | $6.63 | Nova |
| Beta (Stock Volatility) | 1.66 | 1.67 | Lam Research |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Lam Research vs Nova Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Lam Research | 2.62% | 4.54% | 1.03% | 32.09% | 20.43% | 36.87% |
| Nova | 2.94% | -0.01% | -8.31% | 30.81% | 4.46% | 29.45% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Lam Research | 22.73% | 91.19% | 165.39% | 1,263.82% | 2,529.97% | 3,354.70% |
| Nova | 14.31% | 134.28% | 368.90% | 2,021.07% | 4,585.64% | 9,136.92% |
Performance & Financial Health Analysis: Lam Research vs Nova
| Metric | LRCX | NVMI |
|---|---|---|
| Market Information | ||
| Market Cap | $122.81B | $8.02B |
| Market Cap Category | Large cap | Mid cap |
| 10 Day Avg. Volume | 11,506,543 | 279,150 |
| 90 Day Avg. Volume | 10,144,891 | 286,683 |
| Last Close | $101.75 | $270.30 |
| 52 Week Range | $56.32 - $102.59 | $154.00 - $291.99 |
| % from 52W High | -0.82% | -7.43% |
| All-Time High | $113.00 (Jul 08, 2024) | $291.99 (Jul 07, 2025) |
| % from All-Time High | -9.96% | -7.43% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.51% |
| Quarterly Earnings Growth | 0.69% | 0.76% |
| Financial Health | ||
| Profit Margin (TTM) | 0.29% | 0.28% |
| Operating Margin (TTM) | 0.34% | 0.30% |
| Return on Equity (TTM) | 0.58% | 0.24% |
| Debt to Equity (MRQ) | 45.47 | 24.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $7.77 | $33.56 |
| Cash per Share (MRQ) | $5.04 | $18.52 |
| Operating Cash Flow (TTM) | $6.17B | $244.38M |
| Levered Free Cash Flow (TTM) | $4.61B | $168.62M |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.00% | N/A |
| Last 12-Month Dividend | $0.92 | N/A |
Valuation & Enterprise Metrics Analysis: Lam Research vs Nova
| Metric | LRCX | NVMI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 23.33 | 41.14 |
| Forward P/E | 22.67 | 36.17 |
| PEG Ratio | 22.67 | 36.17 |
| Price to Sales (TTM) | 6.66 | 10.78 |
| Price to Book (MRQ) | 12.45 | 8.13 |
| Market Capitalization | ||
| Market Capitalization | $122.81B | $8.02B |
| Enterprise Value | $122.95B | $7.68B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.67 | 10.32 |
| Enterprise to EBITDA | 19.56 | 32.97 |
| Risk & Other Metrics | ||
| Beta | 1.66 | 1.67 |
| Book Value per Share (MRQ) | $7.77 | $33.56 |
Financial Statements Comparison: Lam Research vs Nova
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | LRCX | NVMI |
|---|---|---|
| Revenue/Sales | $4.72B | $213.36M |
| Cost of Goods Sold | $2.41B | $91.05M |
| Gross Profit | $2.31B | $122.30M |
| Research & Development | $525.90M | $33.23M |
| Operating Income (EBIT) | $1.56B | $63.23M |
| EBITDA | $1.68B | $68.13M |
| Pre-Tax Income | $1.54B | $76.17M |
| Income Tax | $206.06M | $11.35M |
| Net Income (Profit) | $1.33B | $64.82M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | LRCX | NVMI |
|---|---|---|
| Cash & Equivalents | $5.45B | $141.06M |
| Total Current Assets | $13.46B | $875.74M |
| Total Current Liabilities | $5.49B | $401.78M |
| Long-Term Debt | $3.73B | $47.66M |
| Total Shareholders Equity | $9.51B | $982.12M |
| Retained Earnings | $27.56B | N/A |
| Property, Plant & Equipment | N/A | $139.85M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | LRCX | NVMI |
|---|---|---|
| Operating Cash Flow | $1.50B | $73.99M |
| Capital Expenditures | N/A | $-8.86M |
| Free Cash Flow | $1.02B | $59.69M |
| Debt Repayment | $-504.04M | N/A |
| Common Stock Repurchase | $-435.08M | $-20.00M |
Short Interest & Institutional Ownership Analysis
| Metric | LRCX | NVMI |
|---|---|---|
| Shares Short | 30.18M | 1.64M |
| Short Ratio | 2.99 | 6.28 |
| Short % of Float | 0.02% | 0.06% |
| Average Daily Volume (10 Day) | 11,506,543 | 279,150 |
| Average Daily Volume (90 Day) | 10,144,891 | 286,683 |
| Shares Outstanding | 1.30B | 29.28M |
| Float Shares | 1.26B | 29.22M |
| % Held by Insiders | 0.00% | 0.00% |
| % Held by Institutions | 0.88% | 0.77% |
Dividend Analysis & Yield Comparison: Lam Research vs Nova
| Metric | LRCX | NVMI |
|---|---|---|
| Last 12-Month Dividend | $0.92 | N/A |
| Last 12-Month Dividend Yield | 1.00% | N/A |
| 3-Year Avg Annual Dividend | $0.80 | N/A |
| 3-Year Avg Dividend Yield | 0.30% | N/A |
| 3-Year Total Dividends | $2.40 | N/A |
| Ex-Dividend Date | Jun 18, 2025 | N/A |